Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-12-14

Clinical Trial Update: De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing de novo everolimus versus tacrolimus (both with mycophenolate and low-dose corticosteroids) in liver transplantation has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (corticosteroids)
  • Everolimus (everolimus)
  • MycoPhenolate (mycophenolate mofetil)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Rennes University Hospital | Conditions: Liver Transplantation | Phase 3 | Status: WITHDRAWN